0

Angiotensin Converting Enzyme Inhibitor

INQUIRY Add to cart
For Research Use Only | Not For Clinical Use
CATAP35115607
CAS35115-60-7
Structure
MDL NumberMFCD00076208
Molecular Weight1101.26
InChI KeyUUUHXMGGBIUAPW-CSCXCSGISA-N
Description≥95% (TLC)
Assay≥95% (TLC)
Size1MG, 5MG
Storage Conditions−20°C
1

Angiotensin-converting Enzyme Inhibition Alters the Inflammatory and Fibrinolytic Response to Cardiopulmonary Bypass in Children

Gregory A Fleming, Frederic T Billings 4th, Tom M Klein, David P Bichell, Karla G Christian, Mias Pretorius

Pediatr Crit Care Med. 2011 Sep;12(5):532-8.

PMID: 20975611

1

Angiotensin-converting Enzyme Inhibitor and Visceral Angio-Oedema

Hun Sheng Chuah, Daniel O'Donnell

Emerg Med Australas. 2012 Apr;24(2):207-8.

PMID: 22487673

1

Angiotensin-converting Enzyme inhibitor/angiotensin II Receptor Blockers and Pneumonia Risk Among Stroke Patients

Chia-Lin Liu, Wen-Yi Shau, Chi-Shin Wu, Mei-Shu Lai

J Hypertens. 2012 Nov;30(11):2223-9.

PMID: 22929610

1

Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?

Rami Sommerstein, Michael M Kochen, Franz H Messerli, Christoph Gräni

J Am Heart Assoc. 2020 Apr 7;9(7):e016509.

PMID: 32233753

1

Risk Factors for Postoperative Acute Kidney Injury in Pediatric Cardiac Surgery Patients Receiving Angiotensin-Converting Enzyme Inhibitors

Brady S Moffett, Stuart L Goldstein, Michelle Adusei, Julia Kuzin, Princy Mohan, Antonio R Mott

Pediatr Crit Care Med. 2011 Sep;12(5):555-9.

PMID: 21317676

  • Verification code
Contact Us

Send Us a Request

What is your specific need? We will do everything we can to meet your expectations.
Online Inquiry

Online Inquiry

For any inquiry, question or recommendation, please call: or fill out the following form.

  • Verification code

Head Office

  • Tel:
  • Email:

Follow us on

qrcode